Table 2 Effect of ibudilast on heavy drinking and craving.

From: Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Model and predictor variables

Parameter estimate

SE

95% confidence limits

Odds ratio

95% confidence limits

LL

UL

Z

P

LL

UL

Negative mood (POMS)

Medication (IBUD)

0.34

0.69

−1.01

1.69

0.49

0.62

   

Drinking day (no)

−0.13

0.18

−0.48

0.22

−0.74

0.46

   

Med X drinking day

0.21

0.49

−0.76

−0.48

0.42

9.67

   

Heavy drinking

Medication (IBUD)

0.60

0.30

−1.19

−0.02

−2.02

0.04

0.55

0.30

0.98

Time

0.003

0.02

−0.04

0.04

0.16

0.87

1.00

0.96

1.04

Smoking status (nonsmoker)

−0.87

0.32

−1.50

−0.24

−2.71

0.007

0.42

0.22

0.79

Baseline HDD

0.08

0.03

0.03

0.13

2.99

0.003

1.08

1.03

1.14

Craving (AUQ)

Medication (IBUD)

−0.16

0.76

−1.62

1.30

−0.21

0.83

   

Drinking day (no)

−1.06

0.28

−1.61

−0.50

−3.75

<0.001

   

Med X Drinking Day

−0.90

0.49

−1.86

0.06

−1.84

0.07

   
  1. Bolded typeface indicates a significant effect. Italic typeface indicates a trend-level effect.